Nuformix plc
Status: Publicly traded
Direct answer
Nuformix plc is publicly traded on LSE under the ticker NFX.L.
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib,...
Can you invest in Nuformix plc?
Yes. Nuformix plc is publicly traded on LSE under the ticker NFX.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nuformix plc
Detailed equity research is provided by MarketSnap.